Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers

International Journal of Oncology

Volumn 27, Issue 2, 2005, Pages 481-488

  Grepmeier, Ulrikh ^a   Dietmaier, Wolfgang ^a   Merk, Johannes ^b   Wild, Peter J ^a   Obermann, Ellen C ^a   Pfeifer, Michael ^a,c   Hofstaedter, Ferdinand ^a   Hartmann, Arndt ^a   Woenckhaus, Matthias ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Department of Thoracic Surgery ^*  (Germany)

^c Hospital Donaustauf   (Germany)

Author keywords

12p; 2q; Allelic loss; Chromosome 3p; LOH; NSCLC

Indexed keywords

MICROSATELLITE DNA;

ADULT; AGED; ARTICLE; BRONCHUS; CHROMOSOME 11; CHROMOSOME 12; CHROMOSOME 2; CHROMOSOME 3; CHROMOSOME DELETION; COMPARATIVE STUDY; CYTOLOGY; EPITHELIUM CELL; FEMALE; GENETICS; HETEROZYGOSITY LOSS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; SMOKING; TIME;

ADULT; AGED; BRONCHI; CARCINOMA, NON-SMALL-CELL LUNG; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 3; EPITHELIAL CELLS; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; SMOKING; TIME FACTORS;

EID: 33644697320     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.27.2.481     Document Type: Article

References (51)

1. Coleman MP. Gatta G. Verdecehia A. et al: EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol 14 (Suppl 5): 128-149,2003.
2. Levi F, Lucchini F, Negri E, Boyle P and La Vecchia C: Cancer mortality in Europe. 1995-1999, and an overview of trends since 1960. lnt J Cancer 110: 155-169. 2004.
3. Jemal A. Clegg LX, Ward E. et al: Annual report to the nation on the status of cancer. 1975-2001. with a special feature regarding survival. Cancer 101: 3-27. 2004.
4. Crispo A. Brennan P. Jockel KH, et al: The cumulative risk of lung cancer among current, ex-and never-smokers in European men. Br J Cancer 91:1280-1286. 2004.
5. Knoke JD. Shanks TG. Vaughn JW. Thun MJ and Bums DM: Lung cancer mortality is related to age in addition to duration and intensity of cigarette smoking: an analysis of CPS-1 data. Cancer Epidemiol Biomarkers Prev 13: 949-957, 2004.
6. Heelan RT. Melamed MR, Zaman MB. Martini N and Flchingcr BJ: Radiologic diagnosis of oat cell cancer in a high-risk screened population. Radiology 136: 593-601. 1980.
7. Melamed MR. Flchingcr BJ. Zaman MB. Heclan RT. Hallerman ET and Martini N: Detection of true pathologic stage I lung cancer in a screening program and the effect on survival. Cancer 47 (Suppl 5): 1182-1187. 1981.
8. Kubik A. Parkin DM. Khlat M. Erban J. Polak J and Adamec M: Lack of benefit from semi-annual screening for cancer of the lung: follow-up report of a randomized controlled trial on a population of high-risk males in Czechoslovakia, lnt J Cancer 45: 26-33, 1990.
9. Swensen SJ, Jett JR. Hartman TE, et al: Lung cancer screening with CT: Mayo Clinic experience. Radiology 226: 756-761. 2003.
10. Al-Batran SE. Astner ST. Supthut M. et al: Three-dimensional in vitro cocultivation of lung carcinoma cells with human bronchial organ culture as a model for bronchial carcinoma. Am J Respir Cell Mol Biol 21: 200-208. 1999.
11. Gazdar AF and Minna JD: Molecular detection of early lung cancer. J Natl Cancer Inst 91: 299-301. 1999.
12. Niklinski J. Niklinska W. Chyczewski L. Becker HD and Pluygers E: Molecular genetic abnormalities in premalignant lung lesions: biological and clinical implications. Eur J Cancer Prev 10: 213-226. 2001.
13. Wistuba II, Behrens C. Virmani AK. et al: High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res 60: 1949-1960. 2000.
14. Varella-Garcia M. Gemmill RM, Rabenhorst SH. et al: Chromosomal duplication accompanies allelic loss in non-small cell lung carcinoma. Cancer Res 58: 4701-4707. 1998.
15. Wistuba II. Lam S. Behrens C. et al: Molecular damage in the bronchia) epithelium of current and former smokers. J Natl Cancer Inst 89: 1366-1373. 1997.
16. Sanz-Ortega J. Valor C. Saez MC. et al: 3p21, 5q21. 9p21 and 17p13 allelic deletions accumulate in the dysplastic spectrum of laryngeal carcinogenesis and precede malignant transformation. Histol Histopathol 18: 1053-1057. 2003.
17. Caballero OL. Cohen D. Liu Q. et al: Loss of chromosome arms 3p and 9p and inactivation of PI6 (INK4a) in normal epithelium of patients with primary lung cancer. Genes Chromosomes Cancer 32: 119-125. 2001.
18. Mao L. Lee JS. Kurie JM. et al: Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst 89: 857-862. 1997.
19. Kurimoto F, Gemma A. Hosoya Y, et al: Unchanged frequency of loss of heterozygosity and size of the deleted region at 8p21-23 during metastasis of lung cancer, lnt J Mol Med 8: 89-93, 2001.
20. Powell CA. Bueno R. Borczuk AC, et al: Patterns of allelic loss differ in lung adenocarcinomas of smokers and non-smokers. Lung Cancer 39: 23-29. 2003.
21. Boyle JO. Lonardo F. Chang JH. Klimstra D. Rusch V and Dmitrovsky E: Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations. Clin Cancer Res 7: 259-266. 2001.
22. Arvanitis DA. Papadakis E. Zafiropoulos A and Spandidos DA: Fractional allele loss is a valuable marker for human lung cancer detection in sputum. Lung Cancer 40: 55-66. 2003.
23. Vassilakis DA. Sourvinos G. Spandidos DA. Siafakas NM and Bouros D: Frequent genetic alterations at the microsatellite level in cytologic sputum samples of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 162: 1115-1119, 2000.
24. Paraskakis E. Sourvinos G. Passam F. et al. Microsatellite DNA instability and loss of heterozygosity in bronchial asthma. Eur Respir J 22: 951-955. 2003.
25. Khalid A, Pal R, Sasatomi E. et al: Use of microsatellite marker loss of heterozygosity in accurate diagnosis of pancreaticobiliary malignancy from brush cytology samples. Gut 53: 1860-1865. 2004.
26. Heighway J. Knapp T. Boyce L, et al: Expression profiling of primary non-small cell lune cancer for target identification. Oncogene 21: 7749-7763. 2002.
27. Kettunen E. Anttila S. Seppanen JK. et al: Differentially expressed genes in non-small cell lung cancer: expression profiling of cancer-related genes in squamous cell lung cancer. Cancer Genet Cytogenet 149: 98-106. 2004.
28. Spira A. Schembri F. Beane J. Shah V. Liu G and Brody JS: Impact of cigarette smoke on the normal airway transcriptome. Chest 125 (Suppl 5): 115S. 2004.
29. Thiberville L. Bourguignon J. Metayer J. et al: Frequency and prognostic evaluation of 3p21-22 allelic losses in non-small cell lung cancer, Int J Cancer 64: 371-377. 1995.
30. Qiu GH. Tan LK. Loh KS. et al: The candidate tumor suppressor gene BLU. located at the commonly deleted region 3p21.3. is an E2F-regulated. stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. Oncogene 23: 4793-4806. 2004.
31. Lee YC. Wu CT. Shih JY. Jou YS and Chang YL: Frequent allelic deletion at the FHIT locus associated with p53 over-expression in squamous cell carcinoma subtype of Taiwanese non-small cell lung cancers. Br J Cancer 90: 2378-2383. 2004.
32. Clifford SC. Prowse AH. Affara NA. Buys CH and Maher ER: Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis. Genes Chromosomes Cancer 22: 200-209. 1998.
33. Martinez A. Fullwood P. Kondo K. et al: Role of chromosome 3p12-p21 tumour suppressor genes in clear cell renal cell carcinoma: analysis of VHL dependent and VHL independent pathways of tumorigenesis. Mol Pathol 53: 137-144, 2000.
34. Clegg N. Ferguson C, True LD. et al: Molecular characterization of prostatic small-cell neuroendocrine carcinoma. Prostate 55: 55-64, 2003.
35. Narayan G, Pulido HA. Koul S. et al: Genetic analysis identifies putative tumor suppressor sites at 2q35-q36.1 and 2q36.3-q37.1 involved in cervical cancer progression. Oncogene 22: 3489-3499. 2003.
36. Sasaki T. Matsumoto N. Jinno Y, et al: Assignment of the human beta-microseminoprotein gene (MSMB) to chromosome 10q11.2. Cytogenet Cell Genet 72: 177-178. 1996.
37. Brancolini C. Bottega S and Schneider C: Gas2, a growth arrest-specific protein, is a component of the microfilament network system. J Cell Biol 117: 1251-1261. 1992.
38. Kobayashi K. Ouchida M. Tsuji T, et al: Reduced expression of the REIC/Dkk-3 gene by promoter-hypermethylation in human tumor cells. Gene 282: 151-158.2002.
39. Wissmann C, Wild PJ. Kaiser S. et al: WIFI, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer. J Pathol 201: 204-212. 2003.
40. Chen L. O'Bryan JP. Smith HS and Liu E: Overexpression of matrix Gla protein mRNA in malignant human breast cells: isolation by differential cDNA hybridization. Oncogene 5: 1391-1395, 1990.
41. Fan C, Sheu D. Fan H, Hsu K, Allen Chang C and Chan E: Down-regulation of matrix Gla protein messenger RNA in human colorectal adenocarcinomas. Cancer Lett 165: 63-69. 2001.
42. Levedakou EN, Strohmeyer TG. Effert PJ and Liu ET: Expression of the matrix Gla protein in urogenital malignancies. Int J Cancer 52: 534-537. 1992.
43. Woenckhaus M. Stoehr R. Dietmaier W. et al: Microsatellite instability at chromosome 8p in non-small cell lung cancer is associated with lymph node metastasis and squamous differentiation. Int J Oncol 23: 1357-1363. 2003.
44. Barsky SH. Roth MD. Kleerup EC. Simmons M and Tashkin DP: Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco. J Natl Cancer Inst 90: 1198-1205. 1998.
45. Wistuba II and Gazdar AF; Molecular pathology of lung cancer. Verh Dtsch Ges Pathol 84: 96-105. 2000.
46. Fong KM, Biesterveld EJ. Virmani A. et al: FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Cancer Res 57: 2256-2267, 1997.
47. Kishimoto Y. Sugio K. Hung JY. et al: Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small cell lung cancers. J Natl Cancer Inst 87: 1224-1229. 1995.
48. Wistuba II. Mao L and Gazdar AF: Smoking molecular damage in bronchial epithelium. Oncogene 21: 7298-7306. 2002.
49. Sheikh MS. Shao ZM. Chen JC and Fontana JA: Differential regulation of matrix Gla protein (MGP) gene expression by retinoic acid and estrogen in human breast carcinoma cells. Mol Cell Endocrinol 92: 153-160. 1993.
50. Patriarea C. Pruneri G. Alfano RM. et al: Polysialylated N-CAM. chromogranin A and B. and secretogranin II in neuroendocrine tumours of the lung. Virchows Arch 430: 455-460. 1997.
51. Mazieres J. He B. You L. et al: Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer. Cancer Res 64: 4717-4720. 2004.